- Home
- INMD vs TLRY Comparison
INMD vs TLRY Comparison
Compare INMD & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INMD | TLRY |
|---|---|---|
| Founded | 2008 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.2M | 872.6M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INMD | TLRY |
|---|---|---|
| Price | $14.48 | $7.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $16.75 | ★ $103.33 |
| AVG Volume (30 Days) | 1.4M | ★ 3.4M |
| Earning Date | 02-10-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | $370,495,000.00 | ★ $837,323,000.00 |
| Revenue This Year | $5.40 | $7.39 |
| Revenue Next Year | $4.80 | $4.76 |
| P/E Ratio | $10.00 | ★ N/A |
| Revenue Growth | N/A | ★ 0.98 |
| 52 Week Low | $13.14 | $3.51 |
| 52 Week High | $19.78 | $23.20 |
Technical Indicators
Market Signals| Indicator | INMD | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 46.62 | 42.90 |
| Support Level | $14.23 | $7.41 |
| Resistance Level | $14.55 | $8.31 |
| Average True Range (ATR) | 0.54 | 0.43 |
| MACD | -0.13 | -0.04 |
| Stochastic Oscillator | 12.30 | 37.16 |
Price Performance
Historical ComparisonAbout INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.